Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-06 Purchase | 2024-03-08 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Duane Jon R Director | 6,920 | $8.7 | $60,204 | 121,028 (Direct) | View |
2024-03-04 Purchase | 2024-03-06 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 10,684 | $9.38 | $100,216 | 301,733 (Direct) | View |
2024-02-12 Sale | 2024-02-14 9:01 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer | 47,380 | $15.24 | $722,071 | 306,437 (Direct) | View |
2024-02-12 Sale | 2024-02-14 8:53 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 38,618 | $15.24 | $588,538 | 422,125 (Direct) | View |
2024-02-12 Sale | 2024-02-14 8:50 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer | 7,908 | $15.24 | $120,518 | 161,477 (Direct) | View |
2024-02-12 Sale | 2024-02-14 8:42 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 9,846 | $15.24 | $150,053 | 306,292 (Direct) | View |
2024-02-12 Sale | 2024-02-14 8:35 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer | 177,164 | $15.24 | $2,699,979 | 832,774 (Direct) | View |
2023-12-14 Sale | 2023-12-18 4:09 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Kessler Marla L Director | 9,926 | $11.19 | $111,072 | 96,572 (Direct) | View |
2023-11-20 Sale | 2023-11-22 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 3,287 | $9.69 | $31,851 | 217,374 (Direct) | View |
2023-09-15 Purchase | 2023-09-18 5:07 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 36,072 | $8.32 | $300,119 | 188,730 (Direct) | View |
2023-08-14 Sale | 2023-08-16 4:21 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer | 1,976 | $10.04 | $19,839 | 134,172 (Direct) | View |
2023-08-14 Sale | 2023-08-16 4:20 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer | 7,045 | $10.04 | $70,732 | 192,195 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer | 32,752 | $0 | 311,975 (Direct) | View |
2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 37,120 | $0 | 338,853 (Direct) | View |
2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 34,936 | $0 | 429,847 (Direct) | View |
2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 37,120 | $0 | 310,756 (Direct) | View |
2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer | 120,298 | $0 | 1,217,948 (Direct) | View |
2024-03-05 Option Award | 2024-03-07 4:05 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer | 397,314 | $0 | 1,230,088 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 9:01 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer | 81,641 | $0 | 306,437 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 8:53 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 81,641 | $0 | 422,125 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 8:50 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer | 27,213 | $0 | 161,477 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 8:42 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Davis Andrew SVP, Chief Business Officer | 97,968 | $0 | 306,292 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 8:39 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 97,968 | $0 | 323,705 (Direct) | View |
2024-02-08 Tax Withholding | 2024-02-12 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 41,332 | $14.9 | 225,737 (Direct) | View |
2024-01-17 Option Award | 2024-01-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | MCCOURT Thomas A Chief Executive Officer | 249,617 | $0 | 1,009,938 (Direct) | View |
2024-01-17 Option Award | 2024-01-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 57,971 | $0 | 379,102 (Direct) | View |
2024-01-17 Option Award | 2024-01-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | John Minardo Chief Legal Officer | 79,981 | $0 | 272,176 (Direct) | View |
2024-01-17 Option Award | 2024-01-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 85,000 | $0 | 267,069 (Direct) | View |
2023-12-15 Option Award | 2023-12-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner | 1,347 | $0 | 16,510,277 (Direct) | View |
2023-12-15 Option Award | 2023-12-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director | 1,572 | $0 | 128,633 (Direct) | View |
2023-11-16 Tax Withholding | 2023-11-20 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 6,661 | $9.44 | 182,069 (Direct) | View |
2023-09-15 Option Award | 2023-09-19 5:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director | 2,098 | $0 | 127,061 (Direct) | View |
2023-09-15 Option Award | 2023-09-19 5:04 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner | 1,798 | $0 | 16,508,930 (Direct) | View |
2023-08-29 Option Award | 2023-08-31 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Silver Ronald Principal Accounting Officer | 8,000 | $0 | 142,172 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:31 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shepard Jay Director | 22,350 | $0 | 102,244 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:30 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director | 22,350 | $0 | 124,963 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:29 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | McHugh Julie Director | 22,350 | $0 | 162,294 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:29 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Kessler Marla L Director | 22,350 | $0 | 106,498 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:28 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Duane Jon R Director | 22,350 | $0 | 114,108 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:27 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Dreyfus Andrew Director | 22,350 | $0 | 168,980 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:26 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner | 22,350 | $0 | 16,507,132 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 5:26 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Currie Mark G Director | 22,350 | $0 | 544,108 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Moukheibir Catherine Director | 1,586 | $0 | 102,613 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | DENNER ALEXANDER J Sarissa Capital Management LP Director 10% Owner | 1,359 | $0 | 16,484,782 (Direct) | View |